DUTCH COLORECTAL CANCER GROUP. PREOPERATIVE RADIOTHERAPY COMBINED WITH TOTAL MESORECTAL EXCISION FOR RESECTABLE RECTAL CANCER

By E. Kapiteijn, C. Marijnen, I. D. Nagtegaal, H. Putter, W. Steup, T. Wiggers, H. Rutten, Lars Påhlman, B. Glimelius, J. V. Krieken and 2 more. 2001

2,105 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/67cf7effe1d12de821af41020cb3a05eb65b39ef

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. I. Nagtegaal
2. P. Quirke
3. J. H. V. van Krieken
4. C. van de Velde
5. Erik van der Worp
6. MRCSEd S.R. WALSH
7. E. J. Cook
8. Mb Bch

Citations in the corpus

• Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. (2002, methodology): “In the Dutch trial of radiotherapy plus TME, standardization of treatment for rectal cancer was achieved.(8) We evaluated the quality of the mesorectal excision of the patients treated in this trial by examining the resection specimen on arrival at the pathology department.”
• Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer (2005, background): “Increased use of adjuvant and neoadjuvant treatment regimens such as chemotherapy and pre-operative radiotherapy may improve recurrence-free survival [4,5].”